173 related articles for article (PubMed ID: 15862645)
21. A novel method for automatic determination of different stages of multiple sclerosis lesions in brain MR FLAIR images.
Khayati R; Vafadust M; Towhidkhah F; Nabavi SM
Comput Med Imaging Graph; 2008 Mar; 32(2):124-33. PubMed ID: 18055174
[TBL] [Abstract][Full Text] [Related]
22. Measuring brain atrophy in multiple sclerosis.
De Stefano N; Battaglini M; Smith SM
J Neuroimaging; 2007 Apr; 17 Suppl 1():10S-15S. PubMed ID: 17425728
[TBL] [Abstract][Full Text] [Related]
23. Gray and normal-appearing white matter in multiple sclerosis: an MRI perspective.
Vrenken H; Geurts JJ
Expert Rev Neurother; 2007 Mar; 7(3):271-9. PubMed ID: 17341175
[TBL] [Abstract][Full Text] [Related]
24. Automated segmentation of multiple sclerosis lesion subtypes with multichannel MRI.
Wu Y; Warfield SK; Tan IL; Wells WM; Meier DS; van Schijndel RA; Barkhof F; Guttmann CR
Neuroimage; 2006 Sep; 32(3):1205-15. PubMed ID: 16797188
[TBL] [Abstract][Full Text] [Related]
25. Deformation analysis to detect and quantify active lesions in three-dimensional medical image sequences.
Thirion JP; Calmon G
IEEE Trans Med Imaging; 1999 May; 18(5):429-41. PubMed ID: 10416804
[TBL] [Abstract][Full Text] [Related]
26. Clinical correlations of brain lesion distribution in multiple sclerosis.
Vellinga MM; Geurts JJ; Rostrup E; Uitdehaag BM; Polman CH; Barkhof F; Vrenken H
J Magn Reson Imaging; 2009 Apr; 29(4):768-73. PubMed ID: 19306365
[TBL] [Abstract][Full Text] [Related]
27. MR in the diagnosis and monitoring of multiple sclerosis: an overview.
Rovira A; León A
Eur J Radiol; 2008 Sep; 67(3):409-14. PubMed ID: 18434066
[TBL] [Abstract][Full Text] [Related]
28. Optimizing brain MRI protocols in the follow-up of patients with multiple sclerosis T2-weighted MRI of the brain after the administration of gadopentetate dimeglumine.
Taschner CA; Kirsch EC; Scheffler K; Wetzel SG; Schulte-Mönting J; Kappos L; Radü EW
Magn Reson Imaging; 2005 Apr; 23(3):469-74. PubMed ID: 15862648
[TBL] [Abstract][Full Text] [Related]
29. Agreement between different input image types in brain atrophy measurement in multiple sclerosis using SIENAX and SIENA.
Neacsu V; Jasperse B; Korteweg T; Knol DL; Valsasina P; Filippi M; Barkhof F; Rovaris M; Vrenken H;
J Magn Reson Imaging; 2008 Sep; 28(3):559-65. PubMed ID: 18777529
[TBL] [Abstract][Full Text] [Related]
30. White matter changes in multiple sclerosis: correlation of q-space diffusion MRI and 1H MRS.
Assaf Y; Chapman J; Ben-Bashat D; Hendler T; Segev Y; Korczyn AD; Graif M; Cohen Y
Magn Reson Imaging; 2005 Jul; 23(6):703-10. PubMed ID: 16198825
[TBL] [Abstract][Full Text] [Related]
31. Signal abnormalities on 1.5 and 3 Tesla brain MRI in multiple sclerosis patients and healthy controls. A morphological and spatial quantitative comparison study.
Di Perri C; Dwyer MG; Wack DS; Cox JL; Hashmi K; Saluste E; Hussein S; Schirda C; Stosic M; Durfee J; Poloni GU; Nayyar N; Bergamaschi R; Zivadinov R
Neuroimage; 2009 Oct; 47(4):1352-62. PubMed ID: 19371784
[TBL] [Abstract][Full Text] [Related]
32. The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction.
Sanfilipo MP; Benedict RH; Sharma J; Weinstock-Guttman B; Bakshi R
Neuroimage; 2005 Jul; 26(4):1068-77. PubMed ID: 15961046
[TBL] [Abstract][Full Text] [Related]
33. Measurement of whole-brain atrophy in multiple sclerosis.
Pelletier D; Garrison K; Henry R
J Neuroimaging; 2004 Jul; 14(3 Suppl):11S-19S. PubMed ID: 15228755
[TBL] [Abstract][Full Text] [Related]
34. Usability and potential of geostatistics for spatial discrimination of multiple sclerosis lesion patterns.
Marschallinger R; Golaszewski SM; Kunz AB; Kronbichler M; Ladurner G; Hofmann P; Trinka E; McCoy M; Kraus J
J Neuroimaging; 2014; 24(3):278-86. PubMed ID: 23384318
[TBL] [Abstract][Full Text] [Related]
35. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis.
Amato MP; Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; De Stefano N
Neurology; 2008 Aug; 71(9):632-8. PubMed ID: 18725589
[TBL] [Abstract][Full Text] [Related]
36. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis.
De Stefano N; Battaglini M; Stromillo ML; Zipoli V; Bartolozzi ML; Guidi L; Siracusa G; Portaccio E; Giorgio A; Sorbi S; Federico A; Amato MP
Brain; 2006 Aug; 129(Pt 8):2008-16. PubMed ID: 16815879
[TBL] [Abstract][Full Text] [Related]
37. MR image analysis in multiple sclerosis.
Nyul LG; Udupa JK
Neuroimaging Clin N Am; 2000 Nov; 10(4):799-816 ,x. PubMed ID: 11359726
[TBL] [Abstract][Full Text] [Related]
38. A task-specific evaluation of three-dimensional image interpolation techniques.
Grevera GJ; Udupa JK; Miki Y
IEEE Trans Med Imaging; 1999 Feb; 18(2):137-43. PubMed ID: 10232670
[TBL] [Abstract][Full Text] [Related]
39. Quantitative diffusion weighted imaging measures in patients with multiple sclerosis.
Tavazzi E; Dwyer MG; Weinstock-Guttman B; Lema J; Bastianello S; Bergamaschi R; Cosi V; Benedict RH; Munschauer FE; Zivadinov R
Neuroimage; 2007 Jul; 36(3):746-54. PubMed ID: 17498974
[TBL] [Abstract][Full Text] [Related]
40. Comparing MR image intensity standardization against tissue characterizability of magnetization transfer ratio imaging.
Madabhushi A; Udupa JK; Moonis G
J Magn Reson Imaging; 2006 Sep; 24(3):667-75. PubMed ID: 16878312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
